May 9, 2017 / 10:43 AM / 3 months ago

Endo posts 7.7 percent rise in quarterly revenue

May 9 (Reuters) - Endo International Plc reported a 7.7 percent rise in quarterly revenue, helped by strong demand for its newly launched generic drugs.

However, the drugmaker's net loss attributable to shareholders widened to $173.8 million, or 78 cents per share, in the first quarter ended March 31 from $133.9 million, or 60 cents per share, a year earlier.

The company booked an asset impairment charge of $204 million in the latest quarter.

Total revenue rose to $1.04 billion from $963.5 million. (Reporting by Divya Grover in Bengaluru; Editing by Anil D'Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below